Dermira, Inc.

Dermira, Inc.

Dermira, Inc.

Dermira is a development-stage biotech company focused on developing andcommercializing innovative new therapies in dermatology.
Suggest edits
Founded
2010
Raised
$129.5M
Follow us
Also headquartered in Menlo Park
Companies in the same industry
Alexa global traffic share
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4

Add info
Acquired by
Eli Lilly and Co
2
10 Jan 2020
Eli Lilly and Co
Latest funding Show all
$1,500,000
Post-IPO equity - 2016
$51,000,000
Venture capital (Series C) - 2014
Canaan Partners Aisling Capital NEA +5
Location
Menlo Park ,  United States
Headquarters
Explore Menlo Park
Acquisition
Xconomy , FinSMEs

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Eli Lilly and Co
Eli Lilly and Co
Dermira, Inc.
Dermira, Inc.
Bloomberg

Dermira Reminds Investors What Binary Means in Biotech

Stock markets Health
Dermira, Inc.
Dermira, Inc.
Xconomy

Dermira Abandons Acne Drug After Phase 3 Flops, Stock Price Craters

Health
Dermira, Inc.
Dermira, Inc.
Xconomy

Dermira Commits $135M for Global Rights to Roche Eczema Drug

Health